Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | I.K |
| Molecular Weight | 166.0028 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[K+].[I-]
InChI
InChIKey=NLKNQRATVPKPDG-UHFFFAOYSA-M
InChI=1S/HI.K/h1H;/q;+1/p-1
| Molecular Formula | HI |
| Molecular Weight | 127.91241 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | K |
| Molecular Weight | 39.0983 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Variable influences of iodine on the T-cell recognition of a single thyroglobulin epitope. | 2007-07 |
|
| Studies on experimental iodine allergy: 3. Low molecular weight elicitogenic antigens of iodine allergy. | 2004-05 |
|
| Studies on experimental iodine allergy: 1. Antigen recognition of guinea pig anti-iodine antibody. | 2004-05 |
|
| 1H NMR studies of ligand and H/D exchange reactions of cis- and trans-([14]aneN4)(H2O)RhH2+ in aqueous solutions. | 2003-06-02 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:10:31 GMT 2025
by
admin
on
Mon Mar 31 18:10:31 GMT 2025
|
| Record UNII |
1C4QK22F9J
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C797
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.3
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
||
|
EPA PESTICIDE CODE |
75701
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
||
|
FDA ORPHAN DRUG |
190304
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
||
|
WHO-VATC |
QR05CA02
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
||
|
CFR |
21 CFR 184.1634
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
||
|
WHO-VATC |
QV03AB21
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
||
|
CFR |
21 CFR 172.375
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
||
|
WHO-ATC |
R05CA02
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
||
|
WHO-VATC |
QS01XA04
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
||
|
WHO-ATC |
S01XA04
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
18.8
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
||
|
WHO-ATC |
V03AB21
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
D011193
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
8346
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
POTASSIUM IODIDE
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
1C4QK22F9J
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
CHEMBL1141
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
DTXSID7034836
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
1548280
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
7681-11-0
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
77362
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
100000091320
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
5040
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
1C4QK22F9J
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
8597
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | RxNorm | ||
|
m9034
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
231-659-4
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
DB06715
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
4875
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
C47680
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
SUB14985MIG
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
4296
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | |||
|
POTASSIUM IODIDE
Created by
admin on Mon Mar 31 18:10:31 GMT 2025 , Edited by admin on Mon Mar 31 18:10:31 GMT 2025
|
PRIMARY | Description: Colourless crystals or a white, granular powder; odourless. Solubility: Soluble in 0.7 part of water, in 17 parts of ethanol (~750 g/l) TS, in 2 parts of glycerol R, and in 75 parts of acetone R. Category: Antifungal, expectorant. Storage: Potassium iodide should be kept in a well-closed container, protected from light. Definition: Potassium iodide contains not less than 99.0% and not more than 101.0% of KI, calculated with reference to the driedsubstance. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |